Morning Overview on MSN
A new compound from ETH Zurich cut nerve-cell loss in mice with Alzheimer’s
Scientists at ETH Zurich have identified a compound that sharply reduced nerve-cell death in mice engineered to develop ...
Abstract: DNA microarrays, which allow for the parallel analysis of thousands of genes, have become the most popular functional genomic tool in use today. Substantial data sets are currently being ...
There are two key things to know about the new Applied Biosystemsâ„¢ SwiftArrayStudioâ„¢ Microarray Analyzer from Thermo Fisher Scientific, said Ravi Gupta, vice president and general manager of Thermo ...
Abstract: Cancer diagnosis is one of the most important emerging clinical applications of gene expression microarray data. In this work, we aim to develop an automated system for robust and reliable ...
As per precedence Research, the global DNA microarray market size is projected to grow approximately USD 6.13 billion by 2034 from valued at USD 2.28 billion in 2023. It is expanding at a CAGR of 9.4% ...
An international research team led by the University of Vienna has succeeded in developing a new version of RNA building blocks with higher chemical reactivity and photosensitivity. This can ...
Micron Biomedical today announced positive Phase 1/2 data from the first-ever clinical trial of microarray technology in children including infants as young as 9 months old. Successful Phase 1/2 study ...
CAMBRIDGE, Mass. & BRISBANE, Australia--(BUSINESS WIRE)--Vaxxas, a clinical-stage biotechnology company commercializing a novel vaccination platform, today announced the publication of clinical trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results